Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Nitrogen containing other than solely as a nitrogen in an...
Reexamination Certificate
2006-06-20
2009-06-23
Henley, III, Raymond J (Department: 1614)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Nitrogen containing other than solely as a nitrogen in an...
Reexamination Certificate
active
07550509
ABSTRACT:
A method of using carisoprodol comprises informing a user that administration of carisoprodol in the presence of food decreases the Cmaxfor carisoprodol compared to administration in the absence of food. In one embodiment, informing comprises providing printed labeling instructions. Also included are articles comprising a carisoprodol formulation and prescribing information, and methods of manufacturing carisoprodol dosage forms. Included are measures intended to increase the safe use of narrow therapeutic medications with carisoprodol.
REFERENCES:
patent: 4536403 (1985-08-01), Rooks
patent: 6761895 (2004-07-01), Sawada et al.
Remington's Pharmaceutical Sciences; Osol et al., published 1980; pp. 1723-1726.
“Coumadin Tablets”; Physicians' Desk Reference Edition 59; ISBN: 1-56363-497-X; pp. 1039-1044; 2005.
“Soma”; Physicians' Desk Reference Edition 59; ISBN: 1-56363-497-X; p. 1976; 2005.
“Diflucan”; Physicians' Desk Reference Edition 59; ISBN: 1-56363-497-X; pp. 2605-2609; 2005.
“Phenytek Capsules”; Physicians' Desk Reference Edition 59; ISBN: 1-56363-497-X; pp. 2255-2257; 2005.
“Coumadin Tablets”; Prescribing Information; Bristol-Myers Squibb Company; Apr. 2005.
“Meprobamate”; British National Formulary (BNF); ISBN: 0 85369 631 4; p. 180; Mar. 2005.
“Carisoprodol”; British National Formulary (BNF); ISBN: 0 85369 631 4; p. 517; Mar. 2005.
“Carisoprodol”; Healthnotes; http://www.n101.com/HealthNotes/HNs/Drug/Carisoprodol.htm; pp. 1-3; printed Jul. 25, 2005.
“Carisoma Tablets” Summary of Product Characteristics; http://www.forestlabs.com/EthicalProducts/SPC/CarisomaSPC.html; pp. 1-4; printed Aug. 10, 2005.
“Carisoma”; http://www.netdoctor.co.uk/medicines/100003158.html; pp. 1-4; printed Aug. 10, 2005.
“Guidance for Industry Food-Effect Bioavailability and Fed Bioequivalence Studies”; U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER); pp. 1-10; Dec. 2002.
Tredger; “Cytochromes P450-their impact on drug treatment”; Hospital Pharmacist; 9; pp. 167-173; 2002.
Beardsley, et al. Anticonvulsant Serum Levels are Useful Only if the Physician Appropriately Uses Them: An Assessment of the Impact of Providing Serum Level Data to Physicians Epilepsia, Published 1983, vol. 24, pp. 330-335; Entire document, esp. Summary, p. 330; p. 331, Col 1, paraa 3; pp. 331, Col. 2, para 4.
Poolsup, et al. “Pharmacogenetics and Psychopharmacotherapy”, J. Clin. Pharm. Ther. 2000, vol. 25, pp. 197-220.
International Search Report and Written Opinion; International Application No. PCT/US07/21122; International filing date Oct. 1, 2007; Applicant's File No. MPC-0115; Date of Mailing Mar. 10, 2008, 8 pages.
International Search Report dated Dec. 12, 2008 for Application No. PCT/US07/08736.
Du Jie
Roberts Richard H.
Cantor & Colburn LLP
Henley, III Raymond J
Mutual Pharmaceutical Company, Inc.
LandOfFree
Carisoprodol articles and methods does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Carisoprodol articles and methods, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Carisoprodol articles and methods will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4066789